EndoChoice Holdings Inc. (NYSE:GI) shares were up 4% on Friday . The stock traded as high as $5.21 and last traded at $5.15, with a volume of 52,703 shares trading hands. The stock had previously closed at $4.95.

Several research analysts recently weighed in on GI shares. Bank of America Corp. lowered EndoChoice Holdings from a “neutral” rating to an “underperform” rating and set a $10.00 price target on the stock. in a research report on Thursday, March 24th. Zacks Investment Research lowered EndoChoice Holdings from a “hold” rating to a “sell” rating in a research report on Tuesday, May 3rd. Finally, JPMorgan Chase & Co. started coverage on EndoChoice Holdings in a research report on Wednesday, July 13th. They set an “overweight” rating on the stock.

The firm has a 50-day moving average of $4.65 and a 200 day moving average of $5.08. The stock’s market cap is $133.96 million.

EndoChoice Holdings (NYSE:GI) last announced its quarterly earnings data on Wednesday, May 4th. The company reported ($0.68) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.55) by $0.13. The business earned $18.46 million during the quarter, compared to analysts’ expectations of $18.34 million. The business’s revenue was up 10.2% on a year-over-year basis. During the same quarter last year, the firm earned ($1.00) EPS. On average, equities research analysts anticipate that EndoChoice Holdings Inc. will post ($2.01) earnings per share for the current year.

An institutional investor recently raised its position in EndoChoice Holdings stock. Bank of Montreal Can raised its stake in EndoChoice Holdings Inc. (NYSE:GI) by 25.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 566,845 shares of the company’s stock after buying an additional 115,260 shares during the period. Bank of Montreal Can owned about 2.29% of EndoChoice Holdings worth $4,733,000 as of its most recent SEC filing.

Endochoice Holdings, Inc, formerly ECPM Holdings, LLC, is a medical device company. The Company is focused on designing and commercializing a platform of products for gastrointestinal (GI) caregivers. It offers a range of products and services that span single-use devices and infection control products, pathology and imaging systems.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.